Small caps



Georgina Energy - upcoming IPO

Georgina Energy is an energy company offering investors exposure to an increasingly...

2 hours ago
Deep dive

Aminex to progress Ruvuma once farm-out completes

Zubair Corporation will pay US$5mln in two tranches to develop Ntorya

6 hours, 37 minutes ago
Deep dive

S & U defies tough car market as motor finance customers rise to record level

The company continues to trade well and in line with expectations despite a tough car market and...

11 hours, 3 minutes ago
Deep dive

Remote Monitored Systems seeks further opportunities to enhance shareholder...

RMS is "excited by the opportunities at GyroMetric" and has been taking action at Geocurve to...

3 days, 1 hour ago


Full interview: Scancell back in the clinic with a phase II trial of its...

Scancell Holdings PLC's (LON:SCLP) Cliff Holloway tells Proactive London's Andrew Scott they've begun the UK arm of the phase II trial of its flagship skin cancer treatment. The trial is testing the safety and efficacy of SCIB1 in metastatic melanoma patients who are also receiving Merck’s...

3 hours, 35 minutes ago

Research Independent research from the expert Proactive analyst team

Gold & silver

Cora Gold - Refilling the Development Pipeline for Producers in West Africa

Fast-track gold projects are few and far between and projects with relatively low capital...

1 week, 6 days ago

Open Orphan: creating a valuable niche

Open Orphan (ORPH) presents an opportunity to invest in a company targeting value creation and...

1 week, 6 days ago
Pharma & Biotech

Shield Therapeutics PLC: FDA approves broad label for Feraccru

Shield Therapeutics (LON:STX) reports it has achieved the best...

3 weeks ago

Proactive news

Young computer gamer Energy

Bidstack sees epic gains

1 hour, 32 minutes ago

Join Proactive

Get ahead of the curve

First with the equities news

Get our market previews and stories before the main networks.

Widest with the analysis

Not just the FTSE. Read about
opportunities from the whole
equities market.

Closest the source

Hear directors at first-hand
or meet them in person at our events.

In at the start

Watch IPOs and access on the same terms as the institutions.